044sek
0,0 %
Date:2026-03-19Time:17:29:00Latest report:Q3-2026List:First NorthTicker:QCORE
Market Cap:19 msekEnterprise Value:10 msekNet Sales:8,25 msekEarnings:-35,1 msekEmployees:0ISIN:SE0016829824

Ratios

10-year key figure history for Qlucore turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Qlucore with index and moving average MA50 and MA200.

Stockprice:0,44
MA50:0,43
MA200:0,60
Price/MA200:-26,5 %
RSI (14):53,4
Price/MA50:1,7 %

Description

Qlucore develops AI-based software for use in the healthcare sector. The company's precision medicine solutions transform genetic data into decision-making data to create the right treatment for patients. The company's first diagnostic test – for blood cancer in children – has been approved and CE-marked. The company also has tests for lung cancer under development, and is developing the Qlucore Omics Explorer analysis software.

IT Services